Arkolith/Insider Trading/TMCI/Form 4

Scanlan Sean F.

Chief Innovation OfficerTREACE MEDICAL CONCEPTS, INC. (TMCI) · full profile →Form 4 · filed Jan 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 22, 2026Grant(A)263K—$0690K
Jan 21, 2026Option exercise(M)54K$0.72$39K427K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 21, 2026Option exercise(M)54K—$00

Transaction Codes

A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-021450) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML